Showing results (301-310 of 617) with videos related to
Sort By:
Pageof 62
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individualsB W Anderson, G E Peoples, J L Murray, et al.The Journal of Physical Chemistry. B|July 29, 2021
Phospholipids in Motion: High-Resolution <sup>31</sup>P NMR Field Cycling StudiesMary F Roberts, Jingfei Cai, Sivanandam V Natarajan, et al.Gynecologic Oncology|February 13, 2007
Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovaryDavid R Crotzer, Charlotte C Sun, Robert L Coleman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterusD M Gershenson, J J Kavanagh, L J Copeland, et al.Obstetrics and Gynecology|January 1, 1988
Diagnosis of recurrent cervical carcinoma after radical hysterectomyD M Larson, L J Copeland, J M Malone, et al.Obstetrics and Gynecology|March 1, 1987
Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapyD M Larson, C A Stringer, L J Copeland, et al.Obstetrics and Gynecology|December 1, 1986
Central nervous system metastases in epithelial ovarian carcinomaD M Larson, L J Copeland, R P Moser, et al.Gynecologic Oncology|July 1, 1986
Percutaneous nephrostomy catheter use in gynecologic malignancy: M.D. Anderson Hospital experienceB S Dudley, D M Gershenson, J J Kavanagh, et al.Obstetrics and Gynecology|April 1, 1987
Ureteral assessment after radical hysterectomyD M Larson, J M Malone, L J Copeland, et al.Gynecologic Oncology|June 1, 1985
Continuous-infusion vinblastine in refractory carcinoma of the cervix: a phase II trialJ J Kavanagh, L J Copeland, D M Gershenson, et al.Pageof 62